The rise in metastasectomy across cancer types over the past decade

Cancer

Volumn 121, Issue 5, 2015, Pages 747-757

  Bartlett, Edmund K ^a   Simmons, Kristina D ^a   Wachtel, Heather ^a   Roses, Robert E ^a   Fraker, Douglas L ^a   Kelz, Rachel R ^a   Karakousis, Giorgos C ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Breast cancer metastasectomy; Colorectal cancer metastasectomy; Lung cancer metastasectomy; Melanoma metastasectomy; Metastasectomy; Surgical trends

Indexed keywords

ADRENAL CANCER; ADULT; AGE DISTRIBUTION; ARTICLE; BRAIN CANCER; BREAST CANCER; CANCER LOCALIZATION; CANCER MORTALITY; CANCER SURGERY; COLORECTAL CANCER; COMORBIDITY; CONTROLLED STUDY; FEMALE; HOSPITAL PATIENT; HUMAN; INCIDENCE; LIVER CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MELANOMA; METASTASIS RESECTION; PRIORITY JOURNAL; SEX RATIO; SMALL INTESTINE CANCER; SYSTEMIC THERAPY; TREATMENT INDICATION; TREND STUDY; ADRENAL GLAND; BRAIN; BRAIN NEOPLASMS; BREAST TUMOR; COLORECTAL NEOPLASMS; INTESTINAL NEOPLASMS; LIVER; LIVER NEOPLASMS; LUNG; LUNG NEOPLASMS; MIDDLE AGED; NEOPLASMS; PATHOLOGY; SECONDARY; SMALL INTESTINE; UTILIZATION;

ADRENAL GLANDS; BRAIN; BRAIN NEOPLASMS; BREAST NEOPLASMS; COLORECTAL NEOPLASMS; FEMALE; HUMANS; INTESTINAL NEOPLASMS; INTESTINE, SMALL; LIVER; LIVER NEOPLASMS; LUNG; LUNG NEOPLASMS; MALE; MELANOMA; METASTASECTOMY; MIDDLE AGED; NEOPLASMS;

EID: 84923304391     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.29134     Document Type: Article

References (39)

1. Hughes KS, Simon R, Songhorabodi S, et al. Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of patterns of recurrence. Surgery. 1986; 100:278-284.
2. McCormack PM, Martini N. The changing role of surgery for pulmonary metastases. Ann Thorac Surg. 1979; 28:139-145.
3. Flickinger JC, Kondziolka D, Lunsford LD, et al. A multi-institutional experience with stereotactic radiosurgery for solitary brain metastasis. Int J Radiat Oncol Biol Phys. 1994; 28:797-802.
4. Hellman S, Weichselbaum RR. Oligometastases. J Clin Oncol. 1995; 13:8-10.
5. Abdalla EK, Vauthey JN, Ellis LM, et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg. 2004; 239:818-825; discussion 825-827.
6. Andreou A, Aloia TA, Brouquet A, et al. Margin status remains an important determinant of survival after surgical resection of colorectal liver metastases in the era of modern chemotherapy. Ann Surg. 2013; 257:1079-1088.
7. Tomlinson JS, Jarnagin WR, DeMatteo RP, et al. Actual 10-year survival after resection of colorectal liver metastases defines cure. J Clin Oncol. 2007; 25:4575-4580.
8. Choti MA, Sitzmann JV, Tiburi MF, et al. Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg. 2002; 235:759-766.
9. Wei AC, Greig PD, Grant D, Taylor B, Langer B, Gallinger S. Survival after hepatic resection for colorectal metastases: a 10-year experience. Ann Surg Oncol. 2006; 13:668-676.
10. Hamady ZZ, Cameron IC, Wyatt J, Prasad RK, Toogood GJ, Lodge JP. Resection margin in patients undergoing hepatectomy for colorectal liver metastasis: a critical appraisal of the 1cm rule. Eur J Surg Oncol. 2006; 32:557-563.
11. Girard P, Ducreux M, Baldeyrou P, et al. Surgery for lung metastases from colorectal cancer: analysis of prognostic factors. J Clin Oncol. 1996; 14:2047-2053.
12. Huang PP, Weber TK, Mendoza C, Rodriguez-Bigas MA, Petrelli NJ. Long-term survival in patients with ovarian metastases from colorectal carcinoma. Ann Surg Oncol. 1998; 5:695-698.
13. Wronski M, Arbit E. Resection of brain metastases from colorectal carcinoma in 73 patients. Cancer. 1999; 85:1677-1685.
14. Moreno P, de la Quintana Basarrate A, Musholt TJ, et al. Adrenalectomy for solid tumor metastases: results of a multicenter European study. Surgery. 2013; 154:1215-1222; discussion 1222-1223. http://www.ncbi.nlm.nih.gov/pubmed?term5de%20la%20Quintana%20Basarrate%20A%5BAuthor%5D&cauthor5true&cauthor-uid524238044.
15. Treasure T, Fallowfield L, Lees B, Farewell V. Pulmonary metasta-sectomy in colorectal cancer: the PulMiCC trial. Thorax. 2012; 67: 185-187.
16. Chua TC, Saxena A, Liauw W, Chu F, Morris DL. Hepatic resection for metastatic breast cancer: a systematic review. Eur J Cancer. 2011; 47:2282-2290.
17. Friedel G, Pastorino U, Ginsberg RJ, et al; International Registry of Lung Metastases, London, England. Results of lung metastasectomy from breast cancer: prognostic criteria on the basis of 467 cases of the International Registry of Lung Metastases. Eur J Cardiothorac Surg. 2002; 22:335-344.
18. Planchard D, Soria JC, Michiels S, et al. Uncertain benefit from surgery in patients with lung metastases from breast carcinoma. Cancer. 2004; 100:28-35.
19. Bonnette P, Puyo P, Gabriel C, et al; Groupe Thorax. Surgical management of non-small cell lung cancer with synchronous brain metastases. Chest. 2001; 119:1469-1475.
20. Tonnies M, Pfannschmidt J, Bauer TT, Kollmeier J, Tonnies S, Kaiser D. Metastasectomy for synchronous solitary non-small cell lung cancer metastases. Ann Thorac Surg. 2014; 98:249-256.
21. Karakousis CP, Velez A, Driscoll DL, Takita H. Metastasectomy in malignant melanoma. Surgery. 1994; 115:295-302.
22. Wasif N, Bagaria SP, Ray P, Morton DL. Does metastasectomy improve survival in patients with Stage IV melanoma? A cancer registry analysis of outcomes. J Surg Oncol. 2011; 104:111-115.
23. Ollila DW. Complete metastasectomy in patients with stage IV metastatic melanoma. Lancet Oncol. 2006; 7:919-924.
24. Saltz LB, Cox JV, Blanke C, et al. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. N Engl J Med. 2000; 343:905-914.
25. Goldberg RM, Sargent DJ, Morton RF, et al. A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol. 2004; 22:23-30.
26. Slamon DJ, Leyland-Jones B, Shak S, et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med. 2001; 344:783-792.
27. Hodi FS, O'Day SJ, McDermott DF, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med. 2010; 363:711-723.
28. Chapman PB, Hauschild A, Robert C, et al; BRIM-3 Study Group. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med. 2011; 364:2507-2516.
29. Heidenreich A, Wilop S, Pinkawa M, Porres D, Pfister D. Surgical resection of urological tumor metastases following medical treatment. Dtsch Arztebl Int. 2012; 109:631-637.
30. Healthcare Cost and Utilization Project (HCUP). Healthcare Cost and Utilization Project Nationwide Inpatient Sample (NIS), 2000-2011. Bethesda, MD: Agency for Healthcare Research and Quality; 2014. www.hcup-us.ahrq.gov/nisoverview.jsp. Accessed May 22, 2014.
31. Healthcare Cost and Utilization Project (HCUP). Healthcare Cost and Utilization Project Clinical Classifications Software (CCS) for ICD-9-CM. Bethesda, MD: Agency for Healthcare Research and Quality; 2014. www.hcup-us.ahrq.gov/toolssoftware/ccs/ccs.jsp. Accessed May 22, 2014.
32. Healthcare Cost and Utilization Project (HCUP). Healthcare Cost and Utilization Project Comorbidity Software, Version 3.7. Bethesda, MD: Agency for Healthcare Research and Quality; 2014. www.hcup-us.ahrq.gov/toolssoftware/comorbidity/comorbidity.jsp. Accessed May 22, 2014.
33. Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998; 36: 8-27.
34. Finks JF, Osborne NH, Birkmeyer JD. Trends in hospital volume and operative mortality for high-risk surgery. N Engl J Med. 2011; 364:2128-2137.
35. Howlader N, Noone AM, Krapcho M, et al, eds. SEER Cancer Statistics Review, 1975-2011. Bethesda, MD: National Cancer Institute; 2014. seer.cancer.gov/csr/1975-2011/. Accessed May 22, 2014.
36. Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000; 19:335-351.
37. Kim HJ, Fay MP, Yu B, Barrett MJ, Feuer EJ. Comparability of segmented line regression models. Biometrics. 2004; 60:1005-1014.
38. Birkmeyer JD, Siewers AE, Finlayson EV, et al. Hospital volume and surgical mortality in the United States. N Engl J Med. 2002; 346:1128-1137.
39. Cady B. Basic principles in surgical oncology. Arch Surg. 1997; 132: 338-346.